NCT03903224

Brief Summary

The aim of this study is to compare the total morphine consumption in the first 24 hour postoperative between combined modified pectoralis block (PECS II) and transversus plane block versus erector spinae block in modified radical mastectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 4, 2019

Completed
1.9 years until next milestone

Study Start

First participant enrolled

February 8, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

2.5 years

First QC Date

March 29, 2019

Last Update Submit

February 16, 2024

Conditions

Keywords

Breast CancerRegional AnaesthesiaMorphine Consumption

Outcome Measures

Primary Outcomes (1)

  • The total morphine consumption postoperative (mg)

    Morphine consumption in mg

    The first 24 hours postoperative.

Secondary Outcomes (4)

  • Postoperative pain score by Verbal numeric rating scale

    0, 2, 4, 8, 12, 24 hours postoperatively.

  • Time to first request analgesia postoperative (min)

    The first 24 hours postoperatively

  • Postoperative level of IL6 (interleukin 6) (pg/mL)

    Two blood samples will be withdrawn from the patient. The first one is immediately preoperative and the second one after 24 hours postoperative

  • Arterial blood gas: Arterial blood gas: Arterial blood gases

    Before surgery and 24 hours postoperative.

Study Arms (2)

Combined PECS II and TTP blocks (PT)

ACTIVE COMPARATOR

Modified Pectoralis block (PECS II) : Using ultrasound we proceed to inject 10 ml of bupivacaine 0.25% between the pectoral muscles and 10 ml under Pmm above the serratus muscle. Transversus Thoracic Plane block : 10 mL bupivacaine (0.25%) is injected between the transversus thoracic muscle and the internal intercostal muscle between the third and fourth left ribs connecting at the sternum.

Procedure: Combined Modified Pectoralis and Transversus Plane Blocks

Erector Spinae Block (E)

ACTIVE COMPARATOR

Using ultrasound an echogenic 22-G block needle is inserted in-plane in a cranial-to-caudal direction until contact is made with the T5 transverse process. A total of 30 bupivacaine 0.25% is then injected while seeing the fluid lifting the erector spinae muscle off.

Procedure: Erector Spinae block

Interventions

Modified pectoralis nerve block (Pecs II) aims to block at least the pectoral nerves, the intercostobrachial, intercostals III-IV-V-VI. This will cover dermatomes T2, T3 and T4. The probe is positioned under the lateral third of the clavicle .After locating the subclavian muscle, the axillary artery and the axillary vein we move the probe distally towards the axilla, until the pectoralis minor is identified. We start counting the ribs , from r1 under the axillary artery, we move distally and laterally until the lateral border of pectoralis minor is reached. The serratus anterior muscle which covers r2, r3, r4 is the point of entrance into the axilla. Blocking of multiple anterior branches of intercostal nerves (Th2-6) using a transversus thoracic muscle plane (TTP) block is used as an additive to pecs II to cover the internal mammary region

Also known as: PECS II and TTP
Combined PECS II and TTP blocks (PT)

The patient is placed in a sitting position and The T5 spinous process is located by palpating and counting down from the C7 spinous process. Under complete aseptic conditions a linear ultrasound probe is then placed in a transverse orientation at the level of the T5 transverse process. The tip of the transverse process is centred on the ultrasound screen and the probe is then rotated into a longitudinal orientation to produce a parasagittal view. From T1 to T5 the erector spinae, rhomboid major and trapezius muscles are visible posterior and superficial to the transverse processes.

Erector Spinae Block (E)

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18: 60 years old
  • ASA (American Society of Anesthesiologists) physical status I II
  • Female patients scheduled for modified radical mastectomy

You may not qualify if:

  • Patient refusal or inability to give informed consent
  • Subjects with a medical contraindication to regional anesthesia , such as coagulopathy, local infection or an allergy to local anesthetic
  • Body mass index (BMI) \>35
  • Presence of psychiatric diseases
  • History of chronic chest wall pain or neuropathic disorders
  • Alcohol or drug abuse
  • Severe chest wall deformities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospital

Asyut, 71515, Egypt

Location

Related Publications (1)

  • Gurkan Y, Aksu C, Kus A, Yorukoglu UH, Kilic CT. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: A randomized controlled study. J Clin Anesth. 2018 Nov;50:65-68. doi: 10.1016/j.jclinane.2018.06.033. Epub 2018 Jul 2.

    PMID: 29980005BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsPain, Postoperative

Interventions

thiamine triphosphorate

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Eman A Ismail, A Lectuer

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor doctor of anaesthesia and ICU Faculty of Medicine - Assiut University

Study Record Dates

First Submitted

March 29, 2019

First Posted

April 4, 2019

Study Start

February 8, 2021

Primary Completion

August 1, 2023

Study Completion

November 1, 2023

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations